SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-226862
Filing Date
2023-09-01
Accepted
2023-09-01 07:34:31
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d550045ds3.htm S-3 266490
2 EX-5.1 d550045dex51.htm EX-5.1 8026
3 EX-23.1 d550045dex231.htm EX-23.1 1879
4 EX-FILING FEES d550045dexfilingfees.htm EX-FILING FEES 16950
5 GRAPHIC g550045g0831035418278.jpg GRAPHIC 2533
  Complete submission text file 0001193125-23-226862.txt   298081
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274298 | Film No.: 231230613
SIC: 2834 Pharmaceutical Preparations